Loading...
XSHE
300723
Market cap2.52bUSD
Jul 10, Last price  
39.75CNY
1D
5.05%
1Q
10.36%
IPO
297.50%
Name

ApicHope Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:300723 chart
P/E
P/S
19.26
EPS
Div Yield, %
0.55%
Shrs. gr., 5y
0.81%
Rev. gr., 5y
-11.06%
Revenues
932m
-35.72%
507,566,827792,554,7921,028,297,4641,250,837,3141,380,217,2701,429,554,2971,637,405,5681,675,417,0582,199,214,4222,280,198,6012,503,447,0031,450,230,295932,270,544
Net income
-338m
L-37.45%
32,993,60940,310,10060,420,201137,349,515156,695,293208,224,373143,685,754225,610,586306,915,395290,682,893184,613,308-540,038,952-337,794,599
CFO
46m
P
135,680,7008,741,92334,549,505146,008,439141,348,771238,599,800280,649,860275,221,007438,100,615475,534,829458,051,312-550,424,56246,012,328
Dividend
Jun 03, 20240.21 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ApicHope Pharmaceutical Co., Ltd, along with its various subsidiary entities, operates primarily in the pharmaceutical sector, focusing on the research, development, production, and distribution of medicinal products. The company boasts an extensive portfolio of offerings that address diverse therapeutic needs, including solutions for infectious diseases, pediatric health, cardiovascular conditions, genitourinary disorders, respiratory ailments, liver and digestive problems, and dermatological complaints. Furthermore, they supply a range of anti-inflammatory and pain-relieving medications. This enterprise, established in 2002, maintains its primary operations in Guangzhou, China. It adopted its current name, ApicHope Pharmaceutical Co., Ltd, in December 2021, having previously been known as Yipinhong Pharmaceutical Co.,Ltd.
IPO date
Nov 16, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT